Núcleo Vitro

Núcleo Vitro is a biotechnology startup founded in 2019 that provides in vitro laboratory testing services for the safety and efficacy of health, cosmetic, and pet care products. The company specializes in cell culture, tissue engineering, and biomimetic models as an ethical alternative to animal testing. Their technical core includes proprietary equivalent skin models—such as NVskin, NVmelanin, NVaged, and NVviral—that reconstruct human dermal and epidermal layers to evaluate specific product attributes like antioxidant action, collagen stimulation, and skin hydration. Recently, the company has expanded its capabilities to include antiviral efficacy studies and organ-on-chip technology, which uses microfluidic systems to simulate connected organs for advanced pharmaceutical and nutraceutical research.

These testing solutions are essential for manufacturers and brands that need to scientifically validate product claims and satisfy regulatory requirements without relying on animal models. By delivering reproducible results through their engineered human tissue platforms, Núcleo Vitro supports companies in bringing safer, more innovative products to market. The firm has established a significant operational footprint, having reportedly served hundreds of companies across Brazil and internationally. Led by scientific director Dr. Bibiana Matte, the startup has received national recognition for its innovation in biotechnology and its commitment to advancing alternative research methodologies.